Skip to main content

Closed

TNGX: Tango Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+15.2% / yr

Operating margin-206.2%

ROIC-27.7%

Financially safe

Stretched

Debt / equity0.08×

Interest coverage0.0×

Current ratio27.38×

Tango Therapeutics, Inc.

TNGXNASDAQ Global Market·USD·Closed

Tango Therapeutics, Inc.

TNGXNASDAQ·USD·Closed

$27.18

−1.41%

$27.18

−$0.39 (1.41%)

52W Range

75thpctl

Volume

0.41×avg

Mkt Cap

3.38BUSD

P/E

-32.7TTM

Div Yield

–ann

52W Range

75thpctl

Volume

0.41×avg

Market Cap

3.38BUSD

P/E Ratio

-32.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings